Effects of additive interactions among obesity, visceral adiposity, and sarcopenia on nonalcoholic fatty liver disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Effects of additive interactions among obesity, visceral adiposity, and sarcopenia on nonalcoholic fatty liver disease ; volume:13 ; number:1 ; day:3 ; month:3 ; year:2023 ; pages:1-8 ; date:12.2023
Scientific reports ; 13, Heft 1 (3.3.2023), 1-8, 12.2023
- Klassifikation
-
Ingenieurwissenschaften und Maschinenbau
- Urheber
-
Chung, Goh Eun
Oh, Sohee
Ahn, Dong-Won
Kim, Su Hwan
Jung, Yong Jin
Kim, Ji Won
Kim, Byeong Gwan
Lee, Kook Lae
Jeong, Ji Bong
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-023-30833-3
- URN
-
urn:nbn:de:101:1-2024030410070495419038
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:02 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Chung, Goh Eun
- Oh, Sohee
- Ahn, Dong-Won
- Kim, Su Hwan
- Jung, Yong Jin
- Kim, Ji Won
- Kim, Byeong Gwan
- Lee, Kook Lae
- Jeong, Ji Bong
- SpringerLink (Online service)
Ähnliche Objekte (12)
Association of visceral adiposity index with sarcopenia based on NHANES data
Visceral adiposity syndrome
Serum CC-Chemokine Ligand 2 Is Associated with Visceral Adiposity but Not Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease
Effects of nonalcoholic fatty liver disease on sarcopenia: evidence from genetic methods
Model containing sarcopenia and visceral adiposity can better predict the prognosis of hepatocellular carcinoma: a multicenter study
The interaction between MALAT1 and TUG1 with dietary fatty acid quality indices on visceral adiposity index and body adiposity index
Visceral adiposity, insulin resistance and cancer risk
Fructo-oligosaccharides ameliorate steatohepatitis, visceral adiposity, and associated chronic inflammation via increased production of short-chain fatty acids in a mouse model of non-alcoholic steatohepatitis
Association between visceral adiposity and generalized anxiety disorder (GAD)
Non-alcoholic fatty liver disease
Diagnostic accuracy of the visceral adiposity index in patients with metabolic-associated fatty liver disease: a meta-analysis
Estradiol signaling mediates gender difference in visceral adiposity via autophagy
Association of visceral adiposity index with sarcopenia based on NHANES data
Visceral adiposity syndrome
Serum CC-Chemokine Ligand 2 Is Associated with Visceral Adiposity but Not Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease
Effects of nonalcoholic fatty liver disease on sarcopenia: evidence from genetic methods
Model containing sarcopenia and visceral adiposity can better predict the prognosis of hepatocellular carcinoma: a multicenter study
The interaction between MALAT1 and TUG1 with dietary fatty acid quality indices on visceral adiposity index and body adiposity index
Visceral adiposity, insulin resistance and cancer risk
Fructo-oligosaccharides ameliorate steatohepatitis, visceral adiposity, and associated chronic inflammation via increased production of short-chain fatty acids in a mouse model of non-alcoholic steatohepatitis
Association between visceral adiposity and generalized anxiety disorder (GAD)
Non-alcoholic fatty liver disease
Diagnostic accuracy of the visceral adiposity index in patients with metabolic-associated fatty liver disease: a meta-analysis
Estradiol signaling mediates gender difference in visceral adiposity via autophagy
Association of visceral adiposity index with sarcopenia based on NHANES data
Visceral adiposity syndrome
Serum CC-Chemokine Ligand 2 Is Associated with Visceral Adiposity but Not Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease
Effects of nonalcoholic fatty liver disease on sarcopenia: evidence from genetic methods
Model containing sarcopenia and visceral adiposity can better predict the prognosis of hepatocellular carcinoma: a multicenter study
The interaction between MALAT1 and TUG1 with dietary fatty acid quality indices on visceral adiposity index and body adiposity index
Visceral adiposity, insulin resistance and cancer risk
Fructo-oligosaccharides ameliorate steatohepatitis, visceral adiposity, and associated chronic inflammation via increased production of short-chain fatty acids in a mouse model of non-alcoholic steatohepatitis
Association between visceral adiposity and generalized anxiety disorder (GAD)
Non-alcoholic fatty liver disease
Diagnostic accuracy of the visceral adiposity index in patients with metabolic-associated fatty liver disease: a meta-analysis